Search Results - "Meer, Felix J.M."

Multi‐dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists by Rein, Nienke, Geus, Kristel S., Cannegieter, Suzanne C., Reitsma, Pieter H., Meer, Felix J.M., Lijfering, Willem M.

“…Purpose Multi‐dose drug dispensing (MDD) is a dosing aid that provides patients with disposable bags containing all drugs intended for 1 dosing moment. MDD is…”
Get full text

The relationship between maintenance dosages of three vitamin K antagonists: Acenocoumarol, warfarin and phenprocoumon by van Leeuwen, Yvonne, Rosendaal, Frits R, van der Meer, Felix. J.M

“…Abstract Introduction Vitamin K antagonists of the coumarin type are widely used oral anticoagulants. Objective We developed a transition algorithm for the…”
Get full text

Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism by van der Hulle, Tom, Tan, Melanie, den Exter, Paul L, van Roosmalen, Mark J G, van der Meer, Felix J M, Eikenboom, Jeroen, Huisman, Menno V, Klok, Frederikus A

“…Patients with a second venous thromboembolism generally receive anticoagulant treatment indefinitely, although it is known that the recurrence risk diminishes…”
Get full text

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients by Moort, Iris, Preijers, Tim, Hazendonk, Hendrika C.A.M., Schutgens, Roger E.G., Laros‐van Gorkom, Britta A.P., Nieuwenhuizen, Laurens, Meer, Felix J.M., Fijnvandraat, Karin, Leebeek, Frank W.G., Meijer, Karina, Mathôt, Ron A.A., Cnossen, Marjon H.

“…Aims Under‐ and, especially, overdosing of replacement therapy in haemophilia A patients may be prevented by application of other morphometric variables than…”
Get full text

Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer by van der Hulle, Tom, MD, den Exter, Paul L., MD, van den Hoven, Pim, MD, van der Hoeven, Jacobus J., MD, PhD, van der Meer, Felix J.M., MD, PhD, Eikenboom, Jeroen, MD, PhD, Huisman, Menno V., MD, PhD, Klok, Frederikus A., MD, PhD

“…Background After diagnosis of cancer-associated VTE, guidelines recommend considering the continuation of anticoagulant treatment until the patient is cured of…”
Get full text

Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools by van den Besselaar, Antonius M H P, Abdoel, Charmane F, van Rijn, Claudia J J, van der Meer, Felix J M, Cobbaert, Christa M

“…Background In the Netherlands, each new lot of test strips for the CoaguChek XS is validated by a group of collaborating centers. The purpose of this study was…”
Get more information

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study by Zielinski, Gilda Denise, van Rein, Nienke, Teichert, Martina, Klok, Frederikus A., Rosendaal, Frits R., van der Meer, Felix J.M., Huisman, Menno V., Cannegieter, Suzanne C., Lijfering, Willem M.

“…In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's) are not strictly monitored and dose titrated by anticoagulation clinics in the…”
Get full text

Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INR by Biedermann, Joseph S, Leebeek, Frank W.G, Buhre, Peter N, de Lathouder, Sacha, Barends, Jan P.F, de Maat, Moniek P.M, van der Meer, Felix J.M, Kruip, Marieke J.H.A

“…Abstract Introduction Introducing point-of-care (POC) INR measurement to monitor anticoagulant therapy may be beneficial for both patients and anticoagulation…”
Get full text

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon by Verhoef, Talitha I, Ragia, Georgia, de Boer, Anthonius, Barallon, Rita, Kolovou, Genovefa, Kolovou, Vana, Konstantinides, Stavros, Le Cessie, Saskia, Maltezos, Efstratios, van der Meer, Felix J.M, Redekop, William K, Remkes, Mary, Rosendaal, Frits R, van Schie, Rianne M.F, Tavridou, Anna, Tziakas, Dimitrios, Wadelius, Mia, Manolopoulos, Vangelis G, Maitland-van der Zee, Anke H

“…A genotype-guided dosing algorithm was compared with a clinical dosing algorithm in patients starting anticoagulation with acenocoumarol or phenprocoumon…”
Get full text

Long-term stability of frozen pooled plasmas stored at − 70 °C, − 40 °C, and − 20 °C for prothrombin time and International Normalized Ratio (INR) assessment by van den Besselaar, Anton M.H.P, Witteveen, Evelina, van der Meer, Felix J.M

“…Abstract Background Frozen pooled plasmas may be used for quality assessment and local calibration of prothrombin time (PT) and International Normalized Ratio…”
Get full text

Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia by Vossen, Carla Y, Walker, Isobel D, Svensson, Peter, Souto, Juan C, Scharrer, Inge, Preston, F Eric, Palareti, Gualtiero, Pabinger, Ingrid, van der Meer, Felix J.M, Makris, Mike, Fontcuberta, Jordi, Conard, Jacqueline, Rosendaal, Frits R

“…OBJECTIVE—Few comprehensive data are available on the recurrence rate of venous thrombosis in carriers of thrombophilic defects from thrombophilic families. We…”
Get full text

Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands by Zhang, Yumao, de Boer, Anthonius, Verhoef, Talitha I, van der Meer, Felix J.M, Le Cessie, Saskia, Maitland-van der Zee, Anke H

“…Abstract Background It has not been investigated how much the use of clinical factors in a dosing algorithm improves the percentage of time in therapeutic…”
Get full text

Interpretation and management of INR results: A case history based survey in 13 countries by Kristoffersen, Ann-Helen, Thue, Geir, Ajzner, Eva, Claes, Neree, Horvath, Andrea Rita, Leonetti, Rina, Kallion, Kaja, Kitchen, Dianne, Kitchen, Steve, Kutt, Marge, Meijer, Piet, Muller, Mathias, Nilsson, Elisabeth, Perich, Carmen, Plum, Inger, Rogic, Dunja, Tirimacco, Rosy, van der Meer, Felix J.M, Watine, Joseph, Sandberg, Sverre

“…Abstract Introduction Standardisation of treatment with vitamin K antagonists (VKAs) is still an issue after 60 years of use. The study aimed to explore…”
Get full text

Using the Common-Sense Model to Predict Risk Perception and Disease-Related Worry in Individuals at Increased Risk for Venous Thrombosis by Kaptein, Ad A, van Korlaar, Inez M, Cameron, Linda D, Vossen, Carla Y, van der Meer, Felix J.M, Rosendaal, Frits R

“…Objective: This study applied the Common-Sense Model (CSM) to predict risk perception and disease-related worry in 174 individuals with a genetic…”
Get full text

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data by van Schie, Rianne M.F., Wessels, Judith A.M., le Cessie, Saskia, de Boer, Anthonius, Schalekamp, Tom, van der Meer, Felix J.M., Verhoef, Talitha I., van Meegen, Erik, Rosendaal, Frits R., Maitland-van der Zee, Anke-Hilse

“…Aims Polymorphisms in CYP2C9 and VKORC1 influence patients' phenprocoumon (PHE) and acenocoumarol (ACE) dose requirements. To provide physicians with tools to…”
Get full text

Quality Assessment of CoaguChek Point-of-Care Prothrombin Time Monitors: Comparison of the European Community-Approved Procedure and Conventional External Quality Assessment by Poller, Leon, Keown, Michelle, Ibrahim, Saied A, van der Meer, Felix J.M, van den Besselaar, Anton M.H.P, Tripodi, Armando, Jespersen, Jorgen, European Action on Anticoagulation, Meijer, Pieter, Kluft, Cornelis, European Concerted Action on Thrombosis

“…There is a need for dependable quality assessment (QA) of the widely used CoaguChek point-of-care testing prothrombin time monitor. By use of the prescribed…”
Get full text

Infectious Complications of Central Venous Catheters Increase the Risk of Catheter-Related Thrombosis in Hematology Patients: A Prospective Study by VAN ROODEN, Cornelis J, SCHIPPERS, Emile F, BARGE, Renée M. Y, ROSENDAAL, Frits R, GUIOT, Henri F. L, VAN DER MEER, Felix J. M, EDO MEINDERS, A, HUISMAN, Menno V

“…We studied whether the risk of central venous catheter (CVC) -related thrombosis increased after an episode of CVC-related infection in patients undergoing…”
Get full text

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants by Toorop, Myrthe M.A., van Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., van der Meer, Felix J.M., Cannegieter, Suzanne C., Lijfering, Willem M.

“…Many patients who used vitamin K antagonists (VKAs) for long‐term prevention of thromboembolism are now actively switched to a direct oral anticoagulant…”
Get full text

Sensitivity to activated protein C during the menstrual cycle in women with and without factor VLeiden by van Vliet, Huib A.A.M, Rodrigues, Sharon P, Snieders, Marieke N.E, van der Meer, Felix J.M, Frolich, Marijke, Rosendaal, Frits R, Rosing, Jan, Helmerhorst, Frans M

“…Abstract Introduction Activated protein C (APC) resistance is associated with an increased risk of venous thrombosis. High levels of estradiol and…”
Get full text

Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study by GEBUIS, Edward P. A, ROSENDAAL, Frits R, VAN MEEGEN, Erik, VAN DER MEER, Felix J. M

“…Poor anticoagulant stability in patients using vitamin K antagonists is a risk factor for both bleeding and thrombosis. In previous studies supplementation…”
Get full text